Narayana Hrudayalaya Ltd

Equitas Small Finance Bank Ltd, SpiceJet Ltd, Shaily Engineering Plastics Ltd and India Glycols Ltd are among the other gainers in the BSE's 'A' group today, 17 November 2025.Narayana Hrudayalaya Ltd soared 7.69% to Rs 1888.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 4.92 lakh shares were traded on the counter so far as against the average daily volumes of 36766 shares in the past one month. Equitas Small Finance Bank Ltd spiked 6.41% to Rs 63.92. The stock was the second biggest gainer in 'A' group. On the BSE, 8.34 lakh shares were traded on the counter so far as against the average daily volumes of 2.13 lakh shares in the past one month. SpiceJet Ltd surged 5.98% to Rs 37.6. The stock was the third biggest gainer in 'A' group. On the BSE, 98.94 lakh shares were traded on the counter so far as against the average daily volumes of 101.28 lakh shares in the past one month. Shaily Engineering Plastics Ltd exploded 5.97% to Rs 2781.55. The stock was the fourth biggest gainer in 'A' group. On the BSE, 26579 shares were traded on the counter so far as against the average daily volumes of 17373 shares in the past one month. India Glycols Ltd added 5.52% to Rs 1093.7. The stock was the fifth biggest gainer in 'A' group. On the BSE, 66984 shares were traded on the counter so far as against the average daily volumes of 17003 shares in the past one month. Powered by Capital Market - Live

Profit before tax stood at Rs 295.69 crore during the quarter, registering a growth of 27.5% from the Rs 231.97 crore reported in Q2 FY25. India's revenue stood at Rs 1,234.7 crore, up 8.8% year-on-year (YoY), while revenue from the Cayman Islands was Rs 431.6 crore, up 78.1% YoY. Consolidated EBITDA grew by 28.3% to Rs 426.5 crore in the September 2025 quarter from Rs 332.3 crore in Q2 FY25. EBITDA margin improved to 25.3% in Q2 FY26 as against 24.3% in Q2 FY25. On the margins front, the company's operating margin improved to 24.49% in Q2 FY26, compared with 22.03% recorded in Q2 FY25. Net profit margin advanced to 15.71% in Q2 FY26 from 14.20% registered in Q2 FY25. As of 30 September 2025, the company's total borrowings, net of cash, bank balances, and investments, stood at Rs 246.6 crore. The net debt-to-equity ratio was at 0.06, with foreign currency-denominated debt amounting to $69 million. On a half-year basis, the company's net profit jumped 13.75% to Rs 455.02 crore on a 17.89% rise in revenue from operations to Rs 3,151.06 crore in H1 FY26 over H1 FY25. Dr. Emmanuel Rupert, managing director and group CEO of Narayana Hrudayalaya, said, 'The second quarter of the fiscal year has delivered a strong performance after a steady start to the year. We are pleased to report the highest-ever revenue and profitability at both India and the group level. The performance improvement in India is attributable to strong growth in domestic footfall and improvements in payor mix, along with positive traction from our clinic outreach, resulting in the highest ever profitability margins. Our hospital business in Cayman continues to deliver robust performance, with the insurance business showing strong growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region. The domestic integrated care business continues to be on a strong growth path, with our clinics garnering sizeable footfalls across all locations, providing a positive thrust to the overall business. After a steady start, our domestic insurance business has shown strong momentum this quarter, and we expect to build on this further going forward. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year.' Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities.Powered by Capital Market - Live

Narayana Hrudayalaya Ltd rose 6.98% today to trade at Rs 1876. The BSE Healthcare index is up 0.58% to quote at 44910.98. The index is up 0.01 % over last one month. Among the other constituents of the index, Lincoln Pharmaceuticals Ltd increased 6.25% and Anuh Pharma Ltd added 4.78% on the day. The BSE Healthcare index went up 5.65 % over last one year compared to the 9.18% surge in benchmark SENSEX. Narayana Hrudayalaya Ltd has added 6.81% over last one month compared to 0.01% gain in BSE Healthcare index and 0.89% rise in the SENSEX. On the BSE, 21134 shares were traded in the counter so far compared with average daily volumes of 35081 shares in the past one month. The stock hit a record high of Rs 2371.6 on 27 Jun 2025. The stock hit a 52-week low of Rs 1238.45 on 28 Nov 2024.Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya rose 30.08% to Rs 258.37 crore in the quarter ended September 2025 as against Rs 198.63 crore during the previous quarter ended September 2024. Sales rose 20.28% to Rs 1643.79 crore in the quarter ended September 2025 as against Rs 1366.68 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1643.791366.68 20 OPM %24.4122.60 - PBDT382.95297.21 29 PBT295.48232.47 27 NP258.37198.63 30 Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya rose 30.65% to Rs 137.88 crore in the quarter ended September 2025 as against Rs 105.53 crore during the previous quarter ended September 2024. Sales rose 9.08% to Rs 1019.17 crore in the quarter ended September 2025 as against Rs 934.29 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1019.17934.29 9 OPM %22.4819.54 - PBDT217.57175.27 24 PBT171.30133.77 28 NP137.88105.53 31 Powered by Capital Market - Live

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

Narayana Hrudayalaya UK is a wholly owned subsidiary of Cayman Islands-based Health City Cayman Islands, which is a wholly owned subsidiary of Narayana Hrudayalaya. Practice Plus Group Hospitals is an operator of hospitals in the United Kingdom. The company has 7 hospitals, 3 surgical centers, 2 urgent treatment centers, 3 musculoskeletal/diagnostic centers, 1 ophthalmology center with a total capacity of 330 beds. It had recorded turnover of GBP 250 million estimated in FY25 in the year ended September 2025. Narayana Hrudayalaya said that this acquisition will build upon the international presence of the comapny, following the successful expansion in the Caribbean through Health City Cayman Islands. The total consideration for the acquisition is GBP 188.78 million for the 100% stake, which comprises of 60,001 equity shares of face value of GBP 0.02 each of Practice Plus Group Hospitals. The per share price for the acquisition will be GBP 3146.29. The company further said that the closing date shall be within six business days after the date of the agreement or such other date as may be agreed in writing between the seller and the purchaser. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India along with overseas presence at Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds. The company had reported 2.3% fall in consolidated net profit to Rs 196.1 crore on a 15.4% increase in revenue to Rs 1,507.3 crore in Q1 FY26 as compared with Q1 FY25. The scrip shed 0.85% to currently trade at Rs 1777.70 on the BSE. Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya declined 2.35% to Rs 196.65 crore in the quarter ended June 2025 as against Rs 201.38 crore during the previous quarter ended June 2024. Sales rose 15.39% to Rs 1507.27 crore in the quarter ended June 2025 as against Rs 1306.27 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1507.271306.27 15 OPM %22.3323.15 - PBDT315.14291.80 8 PBT230.83230.51 0 NP196.65201.38 -2 Powered by Capital Market - Live

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live

Profit before tax stood at Rs 253.02 crore during the quarter, registering a growth of 13.86% from Rs 222.22 crore reported in Q4 FY24. India's revenue stood at Rs 1,108.8 crore, up 10.66% year-on-year (YoY), while revenue from the Cayman Islands was Rs 379.7 crore, up 50.2% YoY. Consolidated EBITDA grew by 22.17% to Rs 384.6 crore in the March 2025 quarter from Rs 314.8 crore in Q4 FY24. EBITDA margin improved to 26.1% in Q4 FY25 as against 25.3% in Q4 FY24. On the margins front, the company's operating margin reduced to 24.25% in Q4 FY25, compared with 23.02% recorded in Q4 FY24. Net profit margin declined to 13.30% in Q4 FY25 from 14.91% registered in Q4 FY24. As of March 31, 2025, the company's total borrowings, net of cash, bank balances, and current investments, stood at Rs 533 crore. The net debt-to-equity ratio was at 0.15, with foreign currency-denominated debt amounting to $86.8 million. On a full-year basis, the company's net profit rose 0.11% to Rs 790.16 crore on a 12.12% rise in revenue to Rs 5,482.98 crore in FY25 over FY24. Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said, 'The current financial year demonstrated strong performance across our units, both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both a quarterly and an annual basis at the consolidated level. The performance improvement in India units has been driven by domestic volume pickup, increased realizations, and optimization in payor categories. While our flagships continue to contribute significantly, our Southern Peripheral and North units have shown significant growth this year, and we hope to build on the momentum going forward. The new hospital in Camana Bay is fully functional and is contributing meaningfully to the overall Cayman business. We are excited about the traction in the new hospital and are confident that the region will deliver strong growth going forward. The integrated care business is picking up well, with our new clinics garnering sizeable footfalls. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the overall NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year.' Meanwhile, the board has recommended a final dividend of Rs 4.50 per equity share for the financial year ended March 31, 2025. The record date for determining eligible shareholders has been set as Friday, 1 August 2025. Additionally, the board approved a proposal to seek shareholder approval via special resolution to raise up to Rs 1,500 crore in a financial year through the issuance of debt securities, including non-convertible debentures (NCDs), in one or more tranches on a private placement basis. The securities may be denominated in Indian rupees or foreign currency. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India, along with an overseas presence in the Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds.Powered by Capital Market - Live